Concepedia

Hahdi H. Perfect

HH

Statistics

Publications

5

Citations

215

H-Index

5

Active since

2010

Affiliations

Pfizer (United States)(Current)

Hahdi H. Perfect is an author at Pfizer (United States) specializing in synthetic medicinal chemistry, medicinal chemistry, and chemistry.

Publications per year

2010–2021

5

Publications

5

Commercial Route Research and Development for SGLT2 Inhibitor Candidate Ertugliflozin

Paul Bowles, Steven J. Brenek, Stéphane Caron et al. · Organic Process Research & Development · 2013 · 67 citations

, , +9

Annulation of Thioimidates and Vinyl Carbodiimides to Prepare 2-Aminopyrimidines, Competent Nucleophiles for Intramolecular Alkyne Hydroamination. Synthesis of (−)-Crambidine

Nicholas R. Perl, Nathan D. Ide, Sudeep Prajapati et al. · Journal of the American Chemical Society · 2010 · 62 citations

, , +6

Palbociclib Commercial Manufacturing Process Development. Part I: Control of Regioselectivity in a Grignard-Mediated S<sub>N</sub>Ar Coupling

Shengquan Duan, D.W. Place, Hahdi H. Perfect et al. · Organic Process Research & Development · 2016 · 39 citations

, , +8

Development of a Practical and Convergent Process for the Preparation of Sulopenem

Steven J. Brenek, Stéphane Caron, Esmort Chisowa et al. · Organic Process Research & Development · 2012 · 24 citations

, , +10

A radical chlorodifluoromethylation protocol for late-stage difluoromethylation and its application to an oncology candidate

Depei Meng, Lingchun Li, Adam R. Brown et al. · Cell Reports Physical Science · 2021 · 23 citations · Full text

, , +6

1–5 of 5